Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    DSSTox_CID_3661

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 41,748Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2UCB INC

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    UCB INC

    DOXECITINE; DOXRIBTIMINE

    arrow
    IMCAS World Congress
    Not Confirmed

    UCB INC

    Belgium
    arrow
    IMCAS World Congress
    Not Confirmed

    Patent Expiration Date : 2040-08-19

    DOXECITINE; DOXRIBTIMINE

    US Patent Number : 11649259

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 219792

    Patent Use Code : U-4358

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2040-08-19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    UCB INC

    DOXECITINE; DOXRIBTIMINE

    arrow
    IMCAS World Congress
    Not Confirmed

    UCB INC

    Belgium
    arrow
    IMCAS World Congress
    Not Confirmed

    Patent Expiration Date : 2036-08-07

    DOXECITINE; DOXRIBTIMINE

    US Patent Number : 10471087

    Drug Substance Claim :

    Drug Product Claim :

    Application Number : 219792

    Patent Use Code : U-4358

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2036-08-07

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.